Feedback
Carisoprodol and Meprobamate (INACTIVE as of 02/17/2015 Refer to 2011450)
0090600
Ordering Recommendation
Mnemonic
CARIS
Methodology
Gas Chromatography-Mass Spectrometry
Performed
Mon, Fri
Reported
1-4 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration. 
Collect
Plain red. Also acceptable: Lavender (K2 or K3EDTA) or pink (K2EDTA). 
Specimen Preparation
Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution). 
Remarks
 
Stability
After separation from cells: Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 months 
Reference Interval
Test Number
Components
Therapeutic Range
 Carisoprodol, Blood ScreenLess than 8 µg/mL
Toxic: Greater than or equal to 8 µg/mL
0090526Meprobamate, Blood (INACTIVE as of 2/17/15: Refer to 2011521)
Dose-Related Range5-20 µg/mL
ToxicGreater than 40 µg/mL


Interpretive Data
Adverse effects may include drowsiness, dizziness and headache.

Note
CPT Code(s)
80369; (Alt codes: G6052; 80299)
Components
Component Test Code*Component Chart NameLOINC
0090507Carisoprodol, Blood Screen3437-1
0090526Meprobamate Blood3753-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Carisoprodol and Metabolite
  • Carisoprodol, Urine
  • Rela
  • Sodol
  • Soma
  • Soma Compound
  • Soprodol
  • Soridol
  • Vanadom